Cellular reprogramming converts differentiated cells into induced pluripotent stem cells (iPSCs). However, this process is typically very inefficient, complicating mechanistic studies. We identified and molecularly characterized rare, early intermediates poised to reprogram with up to 95% efficiency, without perturbing additional genes or pathways, during iPSC generation from mouse embryonic fibroblasts. Analysis of these cells uncovered transcription factors (e.g., Tfap2c and Bex2) that are important for reprogramming but dispensable for pluripotency maintenance. Additionally, we observed striking patterns of chromatin hyperaccessibility at pluripotency loci, which preceded gene expression in poised intermediates. Finally, inspection of these hyperaccessible regions revealed an early wave of DNA demethylation that is uncoupled from de novo methylation of somatic regions late in reprogramming. Our study underscores the importance of investigating rare intermediates poised to produce iPSCs, provides insights into reprogramming mechanisms, and offers a valuable resource for the dissection of transcriptional and epigenetic dynamics intrinsic to cell fate change.
INTRODUCTION
Cellular reprogramming refers to the process by which differentiated somatic cells are converted into induced pluripotent stem cells (iPSCs) upon ectopic expression of defined transcription factor (TF) combinations, typically Oct4 (Pou5f1), Klf4, Sox2, and Myc (OKSM) (Takahashi and Yamanaka, 2006) . This technology has enormous potential for regenerative medicine, disease modeling, and drug screening as well as the study of cell fate change following forced redirection of cellular identity (Takahashi and Yamanaka, 2016) . However, reprogramming is generally slow (>2 weeks) and inefficient (<1%), complicating mechanistic studies. Most cells fail to reprogram, indicating the existence of epigenetic barriers as well as the requirement for additional facilitators of this process, which remain largely unidentified. Because cells that do not contribute to successful reprogramming dominate assays that rely on bulk reprogramming cultures, it is imperative to identify and examine those select cells poised to generate iPSCs to gain insights into the underlying mechanisms.
Our laboratory and others previously characterized intermediate stages of reprogramming from mouse embryonic fibroblasts (MEFs) to iPSCs using surface markers (Brambrink et al., 2008; Polo et al., 2012; Stadtfeld et al., 2008) . Briefly, we have shown that Thy1 is expressed by MEFs and intermediates that are refractory to reprogramming but lost by early intermediates with iPSC potential. A subset of Thy1 -intermediates then upregulates SSEA-1 before activating an Oct4-GFP reporter at later time points, which coincides with the acquisition of a stable, transgene-independent pluripotent state. Although SSEA-1 expression significantly enriches for intermediates that successfully progress toward iPSCs, this population remains heterogeneous and inefficient in conventional reprogramming assays (5%-10% reprogramming efficiency).
Recently, the utility of SSEA-1 as a prospective reprogramming marker has been challenged, and other marker combinations, such as CD44 and ICAM1 (O'Malley et al., 2013) or CD49d and CD73 (Lujan et al., 2015) , have been proposed. However, the relevance of ICAM1 has only been demonstrated at a late time point using a highly efficient reprogramming system, whereas CD49d and CD73 were exclusively tested at early stages of reprogramming using an inefficient and heterogeneous retroviral reprogramming system. Thus, there is no current consensus on which markers are the most useful for isolating cells poised to produce iPSCs. Additionally, no previously reported enrichment protocol has achieved reprogramming efficiencies of greater than 10%-15% for early intermediates (Lujan et al., 2015; Polo et al., 2012) . To resolve these discrepancies, it will be critical to compare published markers and identify additional markers using the same reprogramming conditions. Furthermore, it will be important to account for the differential ability of sorted cells to survive and adhere to cell culture plates (plating efficiency) because this could profoundly skew the measure of reprogramming efficiency.
Here we validate that SSEA-1 is an early predictive marker of reprogramming progression when adjusting for plating efficiency. By systematically testing over a dozen additional markers, we found that Sca-1 and either CD73 (on day 3) or epithelial cell adhesion molecule (EpCAM) (on day 6) subdivide the SSEA-1 + population and allow for the enrichment of early intermediates poised to produce iPSCs with unparalleled efficiencies of up to 95%. We finally exploit this approach to define the dynamics of transcription, chromatin accessibility, and DNA methylation patterns in those rare cells poised to produce iPSCs, revealing unexpected principles about the process of TF-induced cell fate change.
RESULTS

Plating Efficiency Profoundly Affects Measures of
Reprogramming Potential ''Three/four'' (3/4) MEFs were derived from mice heterozygous for Col1a1-tetO-OKSM, a tetracycline-inducible polycistronic 4-factor vector; Col1a1-tetO-OKSmCherry, a tetracyclineinducible polycistronic 3-factor vector with a fluorescent reporter; Rosa26-M2rtTA; and an Oct4-GFP knockin allele ( Figure 1A ; Bar-Nur et al., 2014; Stadtfeld et al., 2010) . This system ensures near-homogeneous OKSM expression, is highly reproducible, and allows for temporal control of reprogramming by adding or removing doxycycline (dox). Furthermore, the mCherry allele allows us to track expression of the Oct4, Klf4, Sox2 (OKS) transgene and to differentiate mCherry + reprogramming cells from mCherry -feeders. Unless otherwise specified, all reprogramming assays were performed in the presence of 15% serum, 1,000 U/mL leukemia inhibitory factor (LIF), and 50 mg/mL ascorbic acid (AA). Following dox exposure, a subset of 3/4 MEFs rapidly loses Thy1 and gains SSEA-1 expression ( Figure 1B ). To determine the functional significance of these markers, we employed fluorescence-activated cell sorting (FACS) to isolate Thy1 + ,
Thy1
-SSEA-1 -, and SSEA-1 + intermediates. Sorted cells were then re-plated on feeders and allowed to continue reprogramming for additional days on dox. After a period of dox withdrawal, the numbers of iPSC colonies were determined by alkaline phosphatase (AP) staining to calculate reprogramming efficiencies ( Figure 1A, top) . We confirmed that all dox-independent AP + colonies were Oct4-GFP + ( Figure S1A ) and have previously demonstrated that AP + colonies obtained with this system are Nanog + and support the development of germline chimeras (Bar-Nur et al., 2014) , indicating that they represent bona fide iPSCs. Consistent with our prior results (Polo et al., 2012; Stadtfeld et al., 2008) Figures S1B-S1F ). We chose LD over a single cell assay because LD is more robust, allowing us to more precisely assess a wider range of possible plating efficiencies using fewer plates. Nevertheless, we confirmed that plating efficiencies calculated by LD were equivalent to those determined by sorting single cells for day 3 intermediates (Figure S1G) . 10,000 cells from the same sort were also transferred to 6-well plates to determine reprogramming efficiencies (Figure 1A) . Adjusted reprogramming efficiencies were calculated by dividing reprogramming efficiencies by plating efficiencies for each sorted population. Correcting for plating efficiency improved the overall efficiency of live cells from $1% to $7% on day 3 and from $1% to $12% on day 6 of OKSM induction ( Figure S1H ). Critically, by accounting for plating efficiency, SSEA-1 emerges as an important marker of reprogramming progression at every examined time point ( Figure 1E ), confirming previous observations by our group. Furthermore, studies that concluded that SSEA-1 was not an early predictive marker of reprogramming did not assess differential plating (Lujan et al., 2015; O'Malley et al., 2013) . Finally, the actual reprogramming potential of SSEA-1 + cells is remarkably high ($40% on day 3 and day 6). We conclude that any accurate measure of reprogramming potential must account for plating. Figure 2D ). For markers to have general utility, they must be applicable to other reprogramming systems and conditions. We first analyzed the effects of small molecules that increase reprogramming efficiency (AA, GSKi, and Alk5i) (Bar-Nur et al., 2014; Vidal et al., 2014;  Figure S3 ). SSEA-1 and EpCAM gain as well as VCAM1, Sca-1, CD24, and Podxl loss correlate with reprogramming progression whereas other markers did not. Interestingly, ICAM1 expression appears to be dependent on AA. We next evaluated tail tip fibroblasts (TTFs) derived from neonatal het/het mice. Marker expression is essentially the same as that for MEFs (Figure S4A) . Expression of all markers is similar between het/het MEFs and 3/4 MEFs, with the exception of CD49d, which is expressed more highly and for a prolonged period of time in the 3/4 system ( Figure S4B ). These systems are similar in that they share the Stemcca (polycistronic OKSM) allele. We therefore tested reprogramming of MEFs infected with individual dox-inducible lentiviruses (LVs) for the 4 factors. Remarkably, all progression markers had similar expression patterns in this system compared with het/het MEFs ( Figure S4C ). Finally, we analyzed another secondary system, ''OSKM (Jae),'' which differs from Stemcca in the stoichiometry of the 4 factors and the Klf4 isoform (Carey et al., 2011; Kim et al., 2015) . These MEFs reprogrammed more slowly and with lower efficiency. They respond to dox induction early by losing PDGFRb and gaining Podxl, CEACAM1, and Sca-1 ( Figure S4D ). SSEA-1 is first detectable after day 10 of reprogramming, followed by subsequent expression of CD71, EpCAM, and, finally, c-Kit. This order of marker expression within the SSEA-1 + subset is the same as that in het/het MEFs. We conclude that progression markers are conserved among all examined systems and conditions and, thus, have general applicability.
Revisiting Published Markers
Next, we revisited published markers using the same reprogramming system (3/4 MEFs) and accounting for plating. Figures 3C, S5A , and S5B). However, although these marker combinations were predictive of successful reprogramming early, they tracked with cells that failed to reprogram at later time points.
Surprisingly, CD49d and, to a lesser extent, CD73 correlate with mCherry levels, suggesting that these markers, unlike Thy1 and SSEA-1, predominantly reflect expression strength of the OKS transgene, similar to CD24 (Shakiba et al., 2015; Figure 3D) . To determine whether transgene expression correlates with reprogramming efficiency, we sorted SSEA-1 + mCherry low and mCherry high cells and measured adjusted reprogramming efficiencies ( Figure 3E ). On day 3, higher mCherry levels tracked with increased reprogramming efficiency. However, on day 6, this correlation was gone, similar to our results for CD49d and CD73 ( Figures 3C and 3E ). CD49d, but not CD73, was more highly expressed during the reprogramming of 3/4 MEFs compared with het/het MEFs ( Figures 2B, 2C , and S4B), suggesting that the higher transgene levels in the 3/4 system induce more CD49d expression. To confirm this, we generated MEFs heterozygous or homozygous for Col1a1-OKSM and R26-rtTA and determined the fraction of CD49d + cells on day 3 by flow cytometry. Indeed, CD49d expression correlated with expression of the reprogramming factors ( Figures 3F and 3G ). Finally, we reprogrammed MEFs using individual LVs. On day 3, CD49d expression again corresponded with increased reprogramming factor expression ( Figure 3H ). Thus, CD49d and CD73 appear to be early predictive markers of reprogramming as they enrich for cells with high OKSM levels. Consistent with this, CD73 and CD49d have been shown to be expressed by partially reprogrammed iPSCs, which remain addicted to high levels of exogenous reprogramming factors (Lujan et al., 2015) . This property makes these markers most useful for systems exhibiting heterogeneous expression of OKSM. ICAM1 expression has also been suggested to correlate with reprogramming potential (O'Malley et al., 2013) S5A , and S5B). Together, these data demonstrate that our markers enable further enrichment for cells poised to become iPSCs when combined with SSEA-1.
We next tested combinations of the aforementioned markers. On day 3, Sca-1, VCAM1, CD73, and CD49d are heterogeneously expressed within the SSEA-1 + population ( Figure . In summary, we have dissected the heterogeneity of SSEA-1 + intermediates using additional markers and identified the most critical subsets on day 3 and day 6 ( Figure 4F ). These intermediates are poised to undergo successful reprogramming at unparalleled efficiencies of up to 50% on day 3 and 95% on day 6.
Somatic Extinction Precedes Pluripotency Induction in Poised Intermediates
Poised intermediates are a unique tool to dissect the mechanisms of successful reprogramming. We therefore compared day 3 Eff and day 6 Eff cells molecularly with corresponding day 3 Ineff and day 6 Ineff (SSEA-1 + EpCAM -Sca-1 + ) intermediates as well as the starting MEFs and resulting iPSCs by RNAseq, assay for transposase-accessible chromatin sequencing (ATAC-seq), and whole genome bisulfite sequencing (WGBS) ( Figure 4F ). We initially focused on transcriptional analyses to define gene expression patterns that may account for the striking differences in reprogramming potential. Multidimensional scaling (MDS) illustrates a clear trajectory of transcriptional changes that delineates the successful path to reprogramming ( Figure 5A ). Of note, day 6 Ineff intermediates appear to be stalled and fail to progress beyond day 3 intermediates, whereas day 6 Eff cells proceed toward iPSCs. Consistent with Polo et al. (2012) , we observed two waves of transcriptional changes: from MEFs to day 3 SSEA-1 + cells and from day 6 SSEA-1 + cells to iPSCs ( Figure 5B ; Table S1 ). Importantly, day 3 Eff cells were more different from MEFs than day 3 Ineff cells, whereas day 6 Eff cells were more similar to iPSCs than day 6 Ineff cells, suggesting that Eff intermediates are more effective at silencing the somatic program on day 3 and activating the pluripotency program at day 6. Comparing Eff with Ineff intermediates, we detected 264 differentially expressed genes (DEGs) on day 3 and 2,209 DEGs on day 6 (Figures 5B and 5C; Table S2 ). Most day 3 DEGs (190) overlap with day 6 DEGs, suggesting a progression of transcriptional changes. Hierarchical clustering based on day 3 DEGs segregates MEFs from all other samples, indicating that day 3 DEGs are driven by genes that distinguish reprogramming intermediates and iPSCs from MEFs ( Figure 5D , left). By contrast, day 6 DEGs cluster day 6 Eff intermediates with iPSCs, indicating that day 6 Eff but not Ineff cells have initiated an iPSCspecific transcriptional program ( Figure 5D , right).
Cell surface markers differentially expressed between Eff and Ineff intermediates ( Figure S6A ) include genes for CD73, EpCAM, and Sca-1, validating our sorting strategy. Although Ineff and Eff cells are both SSEA-1 + , Fut9, which encodes for the enzyme that produces SSEA-1, was more highly expressed by Eff intermediates. Consistent with this observation, SSEA-1 levels positively correlate with adjusted reprogramming efficiencies ( Figure S6B ). Collectively, these results demonstrate that early transcriptional changes in the select cells poised to successfully reprogram are driven first by effective extinction of the somatic program on day 3 and subsequently by activation of pluripotency loci on day 6.
Identification of TFs Important for the Acquisition of Pluripotency
We next focused on differentially expressed TFs because these may drive differences in reprogramming potential. Several known pluripotency factors were more highly expressed by day 6 Eff compared with day 6 Ineff cells, including Nanog, Prdm14, Lin28, Zscan10, Zfp42, etc. (Table S2 ). However, only 11 TFs were more highly expressed in Eff relative to Ineff cells on both day 3 and day 6. We selected 8 for small interfering RNA (siRNA) suppression (Figures 5E and 5F). siRNAs targeting Myb, Utf1, Bex2, Tfap2c, and Nr0b1 significantly reduced reprogramming efficiencies compared with the Luciferase control. Nr5a2, which can replace Oct4 in reprogramming (Heng et al., 2010) , had no effect in our assay, which may be due to functional redundancy. Nr0b1 and Utf1 have established roles in reprogramming (Buganim et al., 2012; Lujan et al., 2015) , whereas Bex2, Tfap2c, and Myb may be novel regulators of induced pluripotency.
Tfap2c (aka Tcfap2c) encodes for AP-2g. To validate its functional importance, we reprogrammed Tfap2c fl/fl MEFs (Schemmer et al., 2013) with LV-Stemcca. Deletion of Tfap2c with LV-Cre resulted in a profound reduction in reprogramming potential ( Figure 5G ). Conversely, overexpression (OE) of Tfap2c increased reprogramming efficiency (Figure 5H, left; Polo et al., 2012) , and this effect was most pronounced in the absence of AA ( Figure S6C ). Furthermore, Tfap2c OE resulted in a striking increase in the fraction of Eff intermediates as well as Oct4-GFP + cells on day 6 ( Figure 5I ). To corroborate the functional role of Bex2 in reprogramming, we infected Bex2 knockout (KO) or littermate control MEFs (Ito et al., 2014) with LV-Stemcca. Contrary to our siRNA results, we found no difference in the number of iPSC-like colonies ( Figure S6D ). We surmise that the high levels of OKSM delivered by LV-Stemcca compensate for the lack of Bex2 during reprogramming but cannot exclude other possibilities, including compensation by other brain-expressed X-linked (BEX) factors in the KO or off-target effects of the siRNA.
In further agreement with a functional role of Bex2 during reprogramming, its OE in het/het MEFs greatly improved reprogramming efficiency ( Figure 5H, right) . Finally, we confirmed that established Tfap2c and Bex2 KO iPSC clones appear normal ( Figure S6E ), consistent with reports indicating that both genes are dispensable for embryonic stem cell (ESC) maintenance (Auman et al., 2002; Ito et al., 2014; Schemmer et al., 2013) . We conclude that Tfap2c is critical for reprogramming, whereas Bex2 enhances reprogramming but is not absolutely required.
To assess whether expression of these TFs corresponds with the emergence of rare intermediates identified by our surface markers, we analyzed reporters for Utf1 and Bex2. Using CRISPR/Cas9 targeting, we generated Utf1-GFP knockin reporter ESCs and derivative het/het reprogrammable MEFs (Figure 5J) . Although there were no GFP + cells on day 3 of reprogramming, we detected rare GFP + cells on day 6, all of which had the immunophenotype of day 6 Eff cells ( Figure 5K ). We next reprogrammed Bex2-GFP MEFs (Ito et al., 2014) and observed a sizable fraction of GFP + cells by day 6, most of which exhibited the surface markers of day 6 Eff cells ( Figure 5L ). Significantly, SSEA-1 + Bex2-GFP + cells were more efficient than GFP -cells at generating iPSCs ( Figure 5M ), confirming that Bex2 expression marks cells poised to reprogram. In summary, we have identified regulators of reprogramming by (Table S1 ).
(C) Venn diagram showing the overlap of day 3 DEGs (comparing day 3 Ineff and day 3 Eff cells) and day 6 DEGs (comparing day 6 Ineff and day 6 Eff cells) (Table S2) comparing the transcriptional profiles of Eff and Ineff SSEA-1 + subpopulations. The majority of these genes were either not detected at all or only at later stages of reprogramming when analyzing bulk cultures or enriching intermediates solely based on SSEA-1 (Mikkelsen et al., 2008; Polo et al., 2012) , highlighting the importance of our high-resolution characterization of progressing intermediates.
Rapid Rewiring of Chromatin States during Reprogramming
Oct4, Sox2, and Klf4 were suggested to act as pioneer factors that initiate cellular reprogramming by binding to closed regions of chromatin, resulting in nucleosome displacement and chromatin remodeling (Soufi et al., 2012) . However, because previous studies analyzed bulk cultures that are dominated by cells that fail to reprogram, chromatin changes specific to those rare cells poised to form iPSCs remain unknown. We therefore performed ATAC-seq, which globally quantifies chromatin accessibility (Buenrostro et al., 2013 ), using our highly enriched intermediates ( Figure 4F ). Principal-component analysis (PCA) reveals a rapid change in chromatin structure following OKSM induction, evident in both day 3 Ineff and Eff cells relative to MEFs, whereas day 6 intermediates are more closely related to iPSCs ( Figure 6A ). This implies that OKSM facilitates transient changes to chromatin accessibility regardless of whether cells progress or stall during reprogramming. We next analyzed the overlap of ATAC-seq peaks between different populations ( Figure 6B ). MEF-specific regions are rapidly closed following reprogramming initiation, whereas a large fraction of ectopic peaks (not open in MEFs or iPSCs) are induced in all intermediates. Although most iPSC-specific regions remain closed, ''early iPSC'' regions are rapidly induced. Significantly, we detected more of these regions in Eff than in Ineff intermediates on both day 3 and day 6 ( Figure 6B, inset) . Furthermore, day 3 Eff cells undergo chromatin closure for a greater number of MEF regions than day 3 Ineff cells ( Figure S6F , left). By contrast, day 6 Eff cells have more open iPSC regions than day 6 Ineff intermediates ( Figure S6F, right) . We conclude that early changes in chromatin accessibility are driven by silencing of the somatic program on day 3, followed by induction of pluripotency regions on day 6, in agreement with our transcriptional analysis.
Critical Pluripotency Regions Are Hyperaccessible in Poised Intermediates
To narrow down ATAC-seq sites of biological relevance, we considered only differentially accessible regions (DARs) that are open in MEFs (MEF > iPSCs) and remain open in day 3 Ineff cells (day 3 Ineff > day 3 Eff) and day 6 Ineff cells (day 6 Ineff > day 6 Eff), yielding 98 regions (Figure 6C , left; Table S3 ). Notably, these regions are more open in day 3 Ineff intermediates relative to MEFs and are completely closed in day 6 Eff cells and iPSCs, suggesting that their closure is critical for successful reprogramming ( Figure 6D, left) . By contrast, 576 DARs are more open in iPSCs (iPSC > MEF), day 3 Eff cells (day 3 Eff > day 3 Ineff), and day 6 Eff cells (day 6 Eff > day 6 Ineff) (Figure 6C, right; Table S3) . Surprisingly, Eff intermediates showed increased accessibility compared with iPSCs for these regions ( Figure 6D , right), suggesting that a transient hyperaccessible chromatin state at these sites is important for successful reprogramming. Hyperaccessibility had not been previously detected in the analysis of bulk reprogramming cultures or SSEA-1 + intermediates (Chronis et al., 2017; Knaupp et al., 2017; Li et al., 2017) , further underscoring the importance of evaluating poised reprogramming subsets. The 576 DARs more open in iPSCs and Eff intermediates include hyperaccessible peaks adjacent to a number of key pluripotency genes ( Figure 6E ; Table S3 ). These encompass genes more highly expressed by Eff cells on both day 3 and day 6 (Bex2, Tfap2c, Nr0b1, Nr5a2, and Mycn) as well as genes not expressed until day 6 or later (Prdm14 and Zscan10). Of particular interest was the region adjacent to Dppa3 (Figure S7A ), which maps to a known super-enhancer (À45 super-enhancer [SE] ) that controls the expression of both Dppa3 and Nanog (Blinka et al., 2016) . Despite the apparent activation of this enhancer as early as day 3, Nanog is not expressed until day 6, specifically by Eff intermediates, and Dppa3 is not expressed until even later. This observation therefore implies that changes to chromatin accessibility, particularly hyperaccessibility, can precede and may be causal to changes in gene expression.
To ascertain which TFs might bind to the 576 DARs more accessible in Eff intermediates and iPSCs, we performed TF motif enrichment analysis. Top hits included Klf4 (p = 7.16 3 10 À60 ) and Oct4/Sox2 (p = 1.09 3 10 À53 ), suggesting that these regions are enriched for direct binding sites of the reprogramming factors. Thus, hyperaccessibility might be due to superphysiological levels of OKS. However, Eff intermediates expressed less or equal amounts of OKS compared with endogenous levels in iPSCs, arguing against this possibility ( Figure S6G ). To verify OKS binding to these hyperaccessible loci, we analyzed ESC chromatin immunoprecipitation sequencing (ChIP-seq) data for Oct4, Sox2, and Klf4 (Chronis et al., 2017) . Most of the hyperaccessible sites were indeed bound by OKS ( Figures 6E and S6H) . Furthermore, 70% of these sites were occupied by a combination of Oct4 and Sox2 ± Klf4, suggesting that cooperative binding may be responsible for hyperaccessibility. Examples include two peaks upstream of Mybl2, the peak between Dppa3 and Nanog, and a peak adjacent to Tfap2c ( Figures 6F, S7A , and S7B). However, we also identified rare DARs not bound by any reprogramming factors, such as the promoter region of Bex2 ( Figures 6E, S6H , and S7C). Motif analysis for this peak suggested a Tfap2c binding site, which was confirmed by published ChIP-seq data (Park et al., 2015) . We conclude that regions of hyperaccessibility, revealed only by dissecting the rare intermediates poised to reprogram, identify key cis-regulatory elements critical for reprogramming.
DNA Methylation and Demethylation Are Uncoupled during Reprogramming
DNA methylation provides another layer of epigenetic regulation. Reprogramming requires demethylation of pluripotency promoters and enhancers, whereas MEF-specific cis-regulatory elements are remethylated (Koche et al., 2011) . Previous studies of bulk or SSEA-1 + intermediates suggest that DNA methylation changes occur late in reprogramming (Knaupp et al., 2017; Lee et al., 2014; Mikkelsen et al., 2008; Milagre et al., 2017; Polo et al., 2012) . To evaluate the dynamics of DNA methylation in our poised intermediates, we performed WGBS ( Figure 4F ). Globally, MEFs and intermediates have similar DNA methylation levels, whereas iPSCs are relatively hypermethylated and cluster separately ( Figure 7A ), consistent with previous observations (Lee et al., 2014; Milagre et al., 2017; Polo et al., 2012) . For regions that become methylated specifically in iPSCs, there were only subtle differences among early intermediates ( Figure 7A , clusters 1-8), confirming that de novo DNA methylation is a late event. Consistent with this, DNMT3A and DNMT3B, which catalyze de novo DNA methylation, are not required for reprogramming (Pawlak and Jaenisch, 2011) . For regions that are hypomethylated in iPSCs relative to MEFs, we detected two clusters that undergo either immediate or delayed demethylation ( Figure 7A , clusters 9 and 10), implying two separable waves of demethylation. Cluster 9 contains DNA regions that are demethylated late in reprogramming and includes regions closest to the promoters of Zfp42, Dppa2, and Dppa4, whereas cluster 10 is composed of regions that are rapidly demethylated, including areas adjacent to Oct4, Klf4, and Nanog, revealing a previously unexplored early wave of demethylation (Table S4) . Importantly, day 6 Eff cells were more demethylated than the other reprogramming intermediates ( Figure 7A ), linking DNA demethylation of specific loci with increased reprogramming efficiency. In support of this observation, PCA for regions in these two clusters demonstrates a clear trajectory of DNA methylation changes during reprogramming ( Figure 7B ). We assumed that the earliest regions of chromatin opening would be at areas of DNA hypomethylation in the starting MEFs, allowing for rapid binding of reprogramming factors (Koche et al., 2011) . Surprisingly, DARs more accessible in day 3 Eff cells, day 6 Eff cells, and iPSCs are hypermethylated in MEFs but rapidly demethylated on day 3, further demethylated in day 6 Eff cells, and remain demethylated in iPSCs ( Figure 7C, center) . Conversely, DARs more open in MEFs, day 3 Ineff cells, and day 6 Ineff cells are hypomethylated in MEFs and undergo methylation only late in reprogramming ( Figure 7C , right). Next we analyzed sets of annotated enhancers defined in ESCs or MEFs (Shen et al., 2012) . For ESC enhancers methylated in MEFs, day 3 intermediates remain predominantly hypermethylated and cluster with MEFs, whereas day 6 intermediates are hypomethylated and cluster with iPSCs, with day 6 Eff cells being the most demethylated ( Figure 7D, left) . Specific differentially methylated regions (DMRs) less methylated in day 3 Eff cells compared with Ineff cells include enhancers for Oct4, Lin28b, Nodal, Tfcp2l1, and Tfap2c, whereas DMRs less methylated in day 6 Eff cells compared with Ineff cells include enhancers for Epcam, Cdh1, Sall1, Sall4, and Tfap2c ( Figure 7E ; Table S5 ). Of note, endogenous Oct4 is not expressed until day 9 ( Figures 2B and 2C) , implying that specific demethylation of enhancers in Eff intermediates can precede transcription. For MEF enhancers that are methylated in iPSCs, all intermediates were hypomethylated, further demonstrating that de novo methylation is not required for the silencing of MEF genes early in reprogramming ( Figure 7D, right) .
DNA demethylation is mediated, in part, by ten-eleven translocation (TET) enzymes (Koh et al., 2011) . Tet2, but not Tet1, is upregulated early in reprogramming specifically in Eff intermediates ( Figure 7F ). To determine whether Tet2 plays a functional role in the formation of Eff intermediates, we transfected cells with siRNA targeting Tet2. Although we observed no effect on day 3, we detected a significant reduction in SSEA-1 + reprogramming intermediates on day 6, suggesting an important role for Tet2 in reprogramming between day 3 and day 6, coinciding with the early wave of DNA demethylation we detected ( Figure 7G ). We conclude that DNA methylation and demethylation are uncoupled during reprogramming. Additionally, our analysis of highly enriched poised reprogramming intermediates has allowed us to uncover a previously unobserved early wave of DNA demethylation.
DISCUSSION
Here we describe cell surface marker combinations allowing us to prospectively isolate and characterize rare intermediates poised to generate iPSCs with unprecedented efficiencies in the absence of additional treatments. Molecular dissection of these key intermediates elucidates transcriptional and epigenetic events specific to early stages of TF-induced pluripotency (Figure 7H) . Altogether, our study provides a valuable resource of surface markers to delineate the various stages of cellular reprogramming and associated transcriptional, chromatin accessibility, and DNA methylation patterns. Our results highlight the importance of controlling for differential plating. We found that reprogramming intermediates are particularly sensitive to the stress of dissociation and cell sorting, resulting in very poor re-plating potentials. This most likely masked the importance of EpCAM as a marker of reprogramming progression in prior studies (Lujan et al., 2015; Polo et al., 2012) . Remarkably, our data show that EpCAM expression, in combination with SSEA-1 expression (E) DNA methylation levels for key ESC enhancers differentially methylated on day 3 (top) or day 6 (center) of reprogramming (Table S5) and Sca-1 loss, enriches for select intermediates poised to reprogram with nearly 95% efficiency. Furthermore, our study resolves controversies regarding the utility of various cell surface markers to track reprogramming intermediates (Brambrink et al., 2008; Lujan et al., 2015; O'Malley et al., 2013; Stadtfeld et al., 2008) . We surmise that these discrepancies are likely due to the use of distinct reprogramming systems. Importantly, our study compares markers in parallel across distinct reprogramming systems and conditions. We confirm that SSEA-1 is an early and robust marker of reprogramming progression. Likewise, we corroborate CD73 and CD49d as early markers. However, instead of signifying progression, these markers correlate with exogenous reprogramming factor expression. Furthermore, CD73 and CD49d switch to negatively predictive markers later in reprogramming, limiting their general utility. Surprisingly, we find that expression of ICAM1 is dependent on AA and is first induced in reprogramming-refractory intermediates and, thus, may not be a predictive marker until late time points. Transcriptional analysis reveals that Tfap2c and Bex2 are induced specifically in Eff intermediates by day 3, representing two of the earliest transcriptional regulators of successful reprogramming. Intriguingly, both genes are adjacent to cis elements that become hyperaccessible exclusively in Eff intermediates. Furthermore, enhancers of Tfap2c become specifically demethylated in Eff cells. Consistent with a functional role, Tfap2c KO MEFs are significantly impaired in the formation of iPSCs, whereas Tfap2c OE augments reprogramming, corroborating our earlier findings (Polo et al., 2012) . Bex2, on the other hand, is dispensable for reprogramming with high levels of OKSM, but OE increases the reprogramming potential. Additionally, activation of endogenous Bex2 correlates well with cells poised to produce iPSCs. Although Bex2 and Tfap2c are both expressed in pluripotent cell lines, neither is required for ESC self-renewal (Auman et al., 2002; Ito et al., 2014; Schemmer et al., 2013) . Our observations provide the basis for future studies aimed at dissecting the mechanisms by which these underexplored TFs specifically facilitate the acquisition but not maintenance of pluripotency.
Our study uncovers that ectopic chromatin accessibility as well as chromatin hyperaccessibility are previously unrecognized hallmarks of successful reprogramming. These data suggest that adoption of an ESC-like chromatin state is insufficient to acquire a stable iPSC state. Instead, a genome-wide increase in chromatin accessibility, combined with focused hyperaccessibility at critical pluripotency loci, correlates with successful reprogramming in our system. Further work remains to determine how these changes in chromatin accessibility correlate with remodeling of histone marks and rewiring of 3D chromatin architecture, both of which can precede transcription (Apostolou et al., 2013; Polo et al., 2012) , similar to what we found for hyperaccessibility.
Finally, our study redefines the molecular dynamics of DNA methylation changes during TF-induced cellular reprogramming. Global analysis of our highly enriched intermediates revealed no overall change in DNA methylation levels. However, when focusing specifically on regions that are demethylated in iPSCs, we were able to uncover two distinct waves of demethylation, including a previously unappreciated early wave most evident in our Eff intermediates. On the other hand, de novo methylation of somatic regions occurs only late, demonstrating that demethylation and remethylation are uncoupled during reprogramming. Furthermore, a comparison of ATAC-seq with WGBS data revealed that regions of chromatin that are hyperaccessible in Eff intermediates are targeted for rapid DNA demethylation, directly linking these two epigenetic processes. We conclude that key molecular changes occur very early in reprogramming but are typically obscured by the overwhelming majority of cells that do not effectively contribute to the generation of iPSCs.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: siRNA Transfection and Analysis Cells were transfected using Lipofectamine 2000 (Thermo Fisher) with pooled siRNA at a final concentration of 15-20 nM. All siRNA pools were esiRNA (Sigma-Aldrich) except for the siRNA targeting Dmrtc2 (GE-Dharmacon). Cells were treated with siRNA at d0, d3, d6, and d9 of reprogramming, after which dox was withdrawn. After 3-5 additional days, dox-independent iPSCs were stained for AP and reprogramming efficiency was determined (see above). Alternatively, d3 and d6 intermediates were analyzed by flow cytometry.
Lentivirus Production and Infections
293T cells were transfected with plasmids for lentiviral (LV) packaging (VSV-G and D8.9) and LV plasmids for either Stemcca, rtTA, Bex2, or Puromycin, to generate individual lentiviruses. MEFs were infected with virus combinations using Polybrene (Sigma). R26-rtTA and either LV-Cre-IRES-Puro or a LV-Puro control followed by puromycin selection prior to reprogramming. Het/het MEFs were infected with either LV-Bex2, LV-Tfap2c, or a LV-Puro control.
Generation of Utf1 Reporter Cells
Utf1-GFP reporter ESC lines were generated through CRISPR/Cas mediated gene targeting. A targeting construct was designed to integrate an E2A-GFP cassette in-frame with the final exon of Utf1. The construct was generated via PCR amplification and Gibson assembly (New England Biolabs) of E2A-GFP flanked on either side by 500bp of homology to the Utf1 locus. The targeting construct was cotransfected using Lipofectamine 2000 (Thermo) with a Utf1-targeting sgRNA (5 0 -GACTGATAACAAAGCTTTAT-3 0 ) and a Cas9 expression construct into V6.5 ESCs that had previously been targeted with doxycycline inducible Col1a1-OKSM and Rosa26-rtTA. One week following the transfection, GFP+ cells were isolated by FACS and clonally expanded for analysis by Southern blot. Positive clones were injected into blastocysts and the resultant embryos were harvested at E15.5 for the preparation of high-grade chimeric MEFs.
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical Analysis
Statistics including the number of replicates, mean, and SD are reported in the Figures and the Figure Legends . Data is judged to be statistically significant by two-tailed Student's t test (p < 0.05), where appropriate.
RNA-seq RNA-seq reads were aligned to the mouse (mm9) reference transcriptome using STAR, a splice-aware alignment program. Read counts over transcripts were calculated using HTSeq based on a current Ensembl annotation file for NCBI37/mm9 assembly. For differential expression analysis the EdgeR package was used. DEGs were determined by a 2-fold or greater difference between two samples and a false discovery rate (FDR) below 0.05.
ATAC-seq ATAC-seq reads were aligned to the mouse (mm9) reference genome using the BWA package. Only fragments with both ends unambiguously mapped to the genome that were longer than 100 bp were used for further analysis. Hotspot was used to detect significant peaks with an FDR cutoff of 0.05. Since the detected peaks were highly consistent between individual biological replicates, we merged replicate peak sets to produce the sets representing each population (MEF, d3 Ineff, d3 Eff, d6 Ineff, d6 Eff, and iPSC). The resulting peak regions were analyzed for changes in read density between populations. For the analysis of overlap between peak regions, we used the cutoff of 30% overlap in at least one of the two compared regions. DARs were determined by RPKM values for peak regions differing by 2-fold or greater between samples and an FDR below 0.05. TF-binding motif analysis was done with AME (http://meme-suite.org/tools/ame).
WGBS
Reads were aligned to the mouse (mm9) reference genome using BSMap. Methylation levels of individual CpGs were determined by observing bisulfite conversion in the aligned read compared to the reference genome. Region methylation levels were computed using CpGs covered by at least 5x in at least 4 samples. Differential methylation analysis was performed by using Fisher's exact test to measure the significance of differential methylation at each CpG in a region. P values of CpGs in a region were combined using Fisher's method to calculate a region p value. Regions covered by at least 3 CpGs, with a p value of less than 0.01, and showing a weighted methylation difference of at least 30% were called differentially methylated.
DATA AND SOFTWARE AVAILABILITY
The accession number for the sequencing data reported in this paper is GEO: GSE106838.
